Recombinant bacteria for mosquito control

Area of Science:

• Microbiology
• Biotechnology
• Vector Control

Background:

• Bacterial insecticides are used for mosquito control but face challenges with cost and efficacy, especially in tropical regions.
• Existing bacterial agents like Bacillus thuringiensis and Bacillus sphaericus have limitations in broad-spectrum efficacy and resistance development.

Purpose of the Study:

• To improve the efficacy and overcome resistance issues associated with bacterial insecticides against mosquito vectors.
• To explore the potential of recombinant DNA technology in creating novel bacterial strains with enhanced mosquitocidal properties.

Main Methods:

• Utilizing recombinant DNA techniques to combine mosquitocidal proteins (Cry and Cyt proteins from Bacillus thuringiensis) with the binary toxin of Bacillus sphaericus within single bacterial strains.
• Investigating the synergistic effects of combined toxins and the role of Cyt1A in overcoming receptor-mediated resistance mechanisms.

Main Results:

• Recombinant strains demonstrated a 10-fold increase in efficacy against Culex species.
• The inclusion of Cyt1A significantly reduced the potential for resistance development and suppressed existing resistance.
• Cyt1A facilitates binary toxin entry into midgut cells independently of specific receptors.

Conclusions:

• Novel recombinant bacterial insecticides offer a promising strategy for more effective control of mosquito vectors.
• These advancements have the potential to impact the control of diseases like filariasis, Dengue fever, and malaria.